These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10714911)

  • 1. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA
    Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
    Castelo-Branco C; Casals E; Figueras F; Sanjuan A; Vicente JJ; Balasch J; Vanrell JA
    Menopause; 1999; 6(2):92-7. PubMed ID: 10374214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
    Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
    Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
    Dansuk R; Unal O; Karageyim Y; Esim E; Turan C
    Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
    Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables.
    Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW
    Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
    Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
    Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
    Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.